Venous thrombosis Clinical Trials

2 recruiting

Venous thrombosis Trials at a Glance

13 actively recruiting trials for venous thrombosis are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in New York, Beijing, and New Haven. Lead sponsors running venous thrombosis studies include Xuanwu Hospital, Beijing, Cardioangiologisches Centrum Bethanien, and Andreas Andersson.

Browse venous thrombosis trials by phase

Treatments under study

About Venous thrombosis Clinical Trials

Looking for clinical trials for Venous thrombosis? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Venous thrombosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Venous thrombosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Deep Venous ThrombosisVenous Thromboembolism
Inari Medical300 enrolled64 locationsNCT05701917
Recruiting
Not Applicable

Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

Deep Venous ThrombosisVenous Thromboembolism
Memorial Sloan Kettering Cancer Center259 enrolled8 locationsNCT07399977
Recruiting

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

ThrombophiliaAntiphospholipid Syndrome (APS)Venous Thrombosis (Disorder)
Infanta Leonor University Hospital600 enrolled2 locationsNCT07372170
Recruiting
Phase 4

Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis

Cerebral Venous Thrombosis
Xuanwu Hospital, Beijing72 enrolled1 locationNCT07352358
Recruiting
Not Applicable

CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

Deep Venous ThrombosisVenous ThromboembolismPulmonary Embolism+2 more
China-Japan Friendship Hospital5,800 enrolled1 locationNCT04211181
Recruiting

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

Cerebral Venous Thrombosis
Hieu Trung Dinh69 enrolled1 locationNCT07083609
Recruiting
Phase 2Phase 3

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Deep Venous Thrombosis
Yale University258 enrolled22 locationsNCT04924322
Recruiting

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Anticoagulant TherapyCerebral Venous ThrombosisAnticoagulant Drugs+6 more
Xuanwu Hospital, Beijing1,486 enrolled1 locationNCT06947707
Recruiting

Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis

Arterial or Venous Thrombosis
Cardioangiologisches Centrum Bethanien200 enrolled2 locationsNCT06650826
Recruiting
Phase 3

Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis

Cerebral Venous Thrombosis
Kafrelsheikh University200 enrolled1 locationNCT06531122
Recruiting

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis

Cerebral Venous Thrombosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1,300 enrolled1 locationNCT04660747
Recruiting

Sequential compression alone for the prevention of deep venous thrombosis in operating theatres

Deep Venous ThrombosisPulmonary EmbolismLaparoscopic Cholecystectomy
Northern Health5,200 enrolled10 locationsACTRN12621001201864
Recruiting

What is the frequency of non-central venous catheter-related venous thrombosis in paediatric intensive care patients?

Venous thrombosis in children
Andreas Andersson150 enrolled1 locationACTRN12615000441516